Study to Evaluate the Safety of Intravenous Oritavancin for the Treatment of Children With Skin Infections

Clinical trial NCT05599295 · COMPLETED

Trial details

NCT number: NCT05599295
Sponsor: Melinta Therapeutics, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Bacterial Skin and Skin Structure Infection

Start date: 2023-06-15
Primary completion: 2025-11-20
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.